Global mRNA Treatment Market Insights, Forecast to 2029
This report presents an overview of global market for mRNA Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of mRNA Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for mRNA Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global mRNA Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for mRNA Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including CureVac, Moderna, BioNTech (Pfizer), Sanofi (Translate Bio), Ethris (AstraZeneca), Kernal Biologics, RaNA Therapeutics and Silence Therapeutics, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of mRNA Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of mRNA Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for mRNA Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global mRNA Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for mRNA Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including CureVac, Moderna, BioNTech (Pfizer), Sanofi (Translate Bio), Ethris (AstraZeneca), Kernal Biologics, RaNA Therapeutics and Silence Therapeutics, etc.
By Company
- CureVac
- Moderna
- BioNTech (Pfizer)
- Sanofi (Translate Bio)
- Ethris (AstraZeneca)
- Kernal Biologics
- RaNA Therapeutics
- Silence Therapeutics
- Vaccine
- Drugs
- Protein Diseases
- Gene Dysfunction Diseases
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of mRNA Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global mRNA Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Protein Diseases
1.3.3 Gene Dysfunction Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global mRNA Treatment Market Perspective (2018-2029)
2.2 Global mRNA Treatment Growth Trends by Region
2.2.1 mRNA Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Treatment Historic Market Size by Region (2018-2023)
2.2.3 mRNA Treatment Forecasted Market Size by Region (2024-2029)
2.3 mRNA Treatment Market Dynamics
2.3.1 mRNA Treatment Industry Trends
2.3.2 mRNA Treatment Market Drivers
2.3.3 mRNA Treatment Market Challenges
2.3.4 mRNA Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue mRNA Treatment by Players
3.1.1 Global mRNA Treatment Revenue by Players (2018-2023)
3.1.2 Global mRNA Treatment Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of mRNA Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global mRNA Treatment Market Concentration Ratio
3.4.1 Global mRNA Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Treatment Revenue in 2022
3.5 Global Key Players of mRNA Treatment Head office and Area Served
3.6 Global Key Players of mRNA Treatment, Product and Application
3.7 Global Key Players of mRNA Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 MRNA TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global mRNA Treatment Historic Market Size by Type (2018-2023)
4.2 Global mRNA Treatment Forecasted Market Size by Type (2024-2029)
5 MRNA TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global mRNA Treatment Historic Market Size by Application (2018-2023)
5.2 Global mRNA Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America mRNA Treatment Market Size (2018-2029)
6.2 North America mRNA Treatment Market Size by Type
6.2.1 North America mRNA Treatment Market Size by Type (2018-2023)
6.2.2 North America mRNA Treatment Market Size by Type (2024-2029)
6.2.3 North America mRNA Treatment Market Share by Type (2018-2029)
6.3 North America mRNA Treatment Market Size by Application
6.3.1 North America mRNA Treatment Market Size by Application (2018-2023)
6.3.2 North America mRNA Treatment Market Size by Application (2024-2029)
6.3.3 North America mRNA Treatment Market Share by Application (2018-2029)
6.4 North America mRNA Treatment Market Size by Country
6.4.1 North America mRNA Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America mRNA Treatment Market Size by Country (2018-2023)
6.4.3 North America mRNA Treatment Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe mRNA Treatment Market Size (2018-2029)
7.2 Europe mRNA Treatment Market Size by Type
7.2.1 Europe mRNA Treatment Market Size by Type (2018-2023)
7.2.2 Europe mRNA Treatment Market Size by Type (2024-2029)
7.2.3 Europe mRNA Treatment Market Share by Type (2018-2029)
7.3 Europe mRNA Treatment Market Size by Application
7.3.1 Europe mRNA Treatment Market Size by Application (2018-2023)
7.3.2 Europe mRNA Treatment Market Size by Application (2024-2029)
7.3.3 Europe mRNA Treatment Market Share by Application (2018-2029)
7.4 Europe mRNA Treatment Market Size by Country
7.4.1 Europe mRNA Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe mRNA Treatment Market Size by Country (2018-2023)
7.4.3 Europe mRNA Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China mRNA Treatment Market Size (2018-2029)
8.2 China mRNA Treatment Market Size by Type
8.2.1 China mRNA Treatment Market Size by Type (2018-2023)
8.2.2 China mRNA Treatment Market Size by Type (2024-2029)
8.2.3 China mRNA Treatment Market Share by Type (2018-2029)
8.3 China mRNA Treatment Market Size by Application
8.3.1 China mRNA Treatment Market Size by Application (2018-2023)
8.3.2 China mRNA Treatment Market Size by Application (2024-2029)
8.3.3 China mRNA Treatment Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia mRNA Treatment Market Size (2018-2029)
9.2 Asia mRNA Treatment Market Size by Type
9.2.1 Asia mRNA Treatment Market Size by Type (2018-2023)
9.2.2 Asia mRNA Treatment Market Size by Type (2024-2029)
9.2.3 Asia mRNA Treatment Market Share by Type (2018-2029)
9.3 Asia mRNA Treatment Market Size by Application
9.3.1 Asia mRNA Treatment Market Size by Application (2018-2023)
9.3.2 Asia mRNA Treatment Market Size by Application (2024-2029)
9.3.3 Asia mRNA Treatment Market Share by Application (2018-2029)
9.4 Asia mRNA Treatment Market Size by Region
9.4.1 Asia mRNA Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia mRNA Treatment Market Size by Region (2018-2023)
9.4.3 Asia mRNA Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America mRNA Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America mRNA Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America mRNA Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America mRNA Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America mRNA Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America mRNA Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America mRNA Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America mRNA Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America mRNA Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America mRNA Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America mRNA Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America mRNA Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America mRNA Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 CureVac
11.1.1 CureVac Company Details
11.1.2 CureVac Business Overview
11.1.3 CureVac mRNA Treatment Introduction
11.1.4 CureVac Revenue in mRNA Treatment Business (2018-2023)
11.1.5 CureVac Recent Developments
11.2 Moderna
11.2.1 Moderna Company Details
11.2.2 Moderna Business Overview
11.2.3 Moderna mRNA Treatment Introduction
11.2.4 Moderna Revenue in mRNA Treatment Business (2018-2023)
11.2.5 Moderna Recent Developments
11.3 BioNTech (Pfizer)
11.3.1 BioNTech (Pfizer) Company Details
11.3.2 BioNTech (Pfizer) Business Overview
11.3.3 BioNTech (Pfizer) mRNA Treatment Introduction
11.3.4 BioNTech (Pfizer) Revenue in mRNA Treatment Business (2018-2023)
11.3.5 BioNTech (Pfizer) Recent Developments
11.4 Sanofi (Translate Bio)
11.4.1 Sanofi (Translate Bio) Company Details
11.4.2 Sanofi (Translate Bio) Business Overview
11.4.3 Sanofi (Translate Bio) mRNA Treatment Introduction
11.4.4 Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2018-2023)
11.4.5 Sanofi (Translate Bio) Recent Developments
11.5 Ethris (AstraZeneca)
11.5.1 Ethris (AstraZeneca) Company Details
11.5.2 Ethris (AstraZeneca) Business Overview
11.5.3 Ethris (AstraZeneca) mRNA Treatment Introduction
11.5.4 Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2018-2023)
11.5.5 Ethris (AstraZeneca) Recent Developments
11.6 Kernal Biologics
11.6.1 Kernal Biologics Company Details
11.6.2 Kernal Biologics Business Overview
11.6.3 Kernal Biologics mRNA Treatment Introduction
11.6.4 Kernal Biologics Revenue in mRNA Treatment Business (2018-2023)
11.6.5 Kernal Biologics Recent Developments
11.7 RaNA Therapeutics
11.7.1 RaNA Therapeutics Company Details
11.7.2 RaNA Therapeutics Business Overview
11.7.3 RaNA Therapeutics mRNA Treatment Introduction
11.7.4 RaNA Therapeutics Revenue in mRNA Treatment Business (2018-2023)
11.7.5 RaNA Therapeutics Recent Developments
11.8 Silence Therapeutics
11.8.1 Silence Therapeutics Company Details
11.8.2 Silence Therapeutics Business Overview
11.8.3 Silence Therapeutics mRNA Treatment Introduction
11.8.4 Silence Therapeutics Revenue in mRNA Treatment Business (2018-2023)
11.8.5 Silence Therapeutics Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global mRNA Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Protein Diseases
1.3.3 Gene Dysfunction Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global mRNA Treatment Market Perspective (2018-2029)
2.2 Global mRNA Treatment Growth Trends by Region
2.2.1 mRNA Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Treatment Historic Market Size by Region (2018-2023)
2.2.3 mRNA Treatment Forecasted Market Size by Region (2024-2029)
2.3 mRNA Treatment Market Dynamics
2.3.1 mRNA Treatment Industry Trends
2.3.2 mRNA Treatment Market Drivers
2.3.3 mRNA Treatment Market Challenges
2.3.4 mRNA Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue mRNA Treatment by Players
3.1.1 Global mRNA Treatment Revenue by Players (2018-2023)
3.1.2 Global mRNA Treatment Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of mRNA Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global mRNA Treatment Market Concentration Ratio
3.4.1 Global mRNA Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Treatment Revenue in 2022
3.5 Global Key Players of mRNA Treatment Head office and Area Served
3.6 Global Key Players of mRNA Treatment, Product and Application
3.7 Global Key Players of mRNA Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 MRNA TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global mRNA Treatment Historic Market Size by Type (2018-2023)
4.2 Global mRNA Treatment Forecasted Market Size by Type (2024-2029)
5 MRNA TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global mRNA Treatment Historic Market Size by Application (2018-2023)
5.2 Global mRNA Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America mRNA Treatment Market Size (2018-2029)
6.2 North America mRNA Treatment Market Size by Type
6.2.1 North America mRNA Treatment Market Size by Type (2018-2023)
6.2.2 North America mRNA Treatment Market Size by Type (2024-2029)
6.2.3 North America mRNA Treatment Market Share by Type (2018-2029)
6.3 North America mRNA Treatment Market Size by Application
6.3.1 North America mRNA Treatment Market Size by Application (2018-2023)
6.3.2 North America mRNA Treatment Market Size by Application (2024-2029)
6.3.3 North America mRNA Treatment Market Share by Application (2018-2029)
6.4 North America mRNA Treatment Market Size by Country
6.4.1 North America mRNA Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America mRNA Treatment Market Size by Country (2018-2023)
6.4.3 North America mRNA Treatment Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe mRNA Treatment Market Size (2018-2029)
7.2 Europe mRNA Treatment Market Size by Type
7.2.1 Europe mRNA Treatment Market Size by Type (2018-2023)
7.2.2 Europe mRNA Treatment Market Size by Type (2024-2029)
7.2.3 Europe mRNA Treatment Market Share by Type (2018-2029)
7.3 Europe mRNA Treatment Market Size by Application
7.3.1 Europe mRNA Treatment Market Size by Application (2018-2023)
7.3.2 Europe mRNA Treatment Market Size by Application (2024-2029)
7.3.3 Europe mRNA Treatment Market Share by Application (2018-2029)
7.4 Europe mRNA Treatment Market Size by Country
7.4.1 Europe mRNA Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe mRNA Treatment Market Size by Country (2018-2023)
7.4.3 Europe mRNA Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China mRNA Treatment Market Size (2018-2029)
8.2 China mRNA Treatment Market Size by Type
8.2.1 China mRNA Treatment Market Size by Type (2018-2023)
8.2.2 China mRNA Treatment Market Size by Type (2024-2029)
8.2.3 China mRNA Treatment Market Share by Type (2018-2029)
8.3 China mRNA Treatment Market Size by Application
8.3.1 China mRNA Treatment Market Size by Application (2018-2023)
8.3.2 China mRNA Treatment Market Size by Application (2024-2029)
8.3.3 China mRNA Treatment Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia mRNA Treatment Market Size (2018-2029)
9.2 Asia mRNA Treatment Market Size by Type
9.2.1 Asia mRNA Treatment Market Size by Type (2018-2023)
9.2.2 Asia mRNA Treatment Market Size by Type (2024-2029)
9.2.3 Asia mRNA Treatment Market Share by Type (2018-2029)
9.3 Asia mRNA Treatment Market Size by Application
9.3.1 Asia mRNA Treatment Market Size by Application (2018-2023)
9.3.2 Asia mRNA Treatment Market Size by Application (2024-2029)
9.3.3 Asia mRNA Treatment Market Share by Application (2018-2029)
9.4 Asia mRNA Treatment Market Size by Region
9.4.1 Asia mRNA Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia mRNA Treatment Market Size by Region (2018-2023)
9.4.3 Asia mRNA Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America mRNA Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America mRNA Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America mRNA Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America mRNA Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America mRNA Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America mRNA Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America mRNA Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America mRNA Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America mRNA Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America mRNA Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America mRNA Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America mRNA Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America mRNA Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 CureVac
11.1.1 CureVac Company Details
11.1.2 CureVac Business Overview
11.1.3 CureVac mRNA Treatment Introduction
11.1.4 CureVac Revenue in mRNA Treatment Business (2018-2023)
11.1.5 CureVac Recent Developments
11.2 Moderna
11.2.1 Moderna Company Details
11.2.2 Moderna Business Overview
11.2.3 Moderna mRNA Treatment Introduction
11.2.4 Moderna Revenue in mRNA Treatment Business (2018-2023)
11.2.5 Moderna Recent Developments
11.3 BioNTech (Pfizer)
11.3.1 BioNTech (Pfizer) Company Details
11.3.2 BioNTech (Pfizer) Business Overview
11.3.3 BioNTech (Pfizer) mRNA Treatment Introduction
11.3.4 BioNTech (Pfizer) Revenue in mRNA Treatment Business (2018-2023)
11.3.5 BioNTech (Pfizer) Recent Developments
11.4 Sanofi (Translate Bio)
11.4.1 Sanofi (Translate Bio) Company Details
11.4.2 Sanofi (Translate Bio) Business Overview
11.4.3 Sanofi (Translate Bio) mRNA Treatment Introduction
11.4.4 Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2018-2023)
11.4.5 Sanofi (Translate Bio) Recent Developments
11.5 Ethris (AstraZeneca)
11.5.1 Ethris (AstraZeneca) Company Details
11.5.2 Ethris (AstraZeneca) Business Overview
11.5.3 Ethris (AstraZeneca) mRNA Treatment Introduction
11.5.4 Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2018-2023)
11.5.5 Ethris (AstraZeneca) Recent Developments
11.6 Kernal Biologics
11.6.1 Kernal Biologics Company Details
11.6.2 Kernal Biologics Business Overview
11.6.3 Kernal Biologics mRNA Treatment Introduction
11.6.4 Kernal Biologics Revenue in mRNA Treatment Business (2018-2023)
11.6.5 Kernal Biologics Recent Developments
11.7 RaNA Therapeutics
11.7.1 RaNA Therapeutics Company Details
11.7.2 RaNA Therapeutics Business Overview
11.7.3 RaNA Therapeutics mRNA Treatment Introduction
11.7.4 RaNA Therapeutics Revenue in mRNA Treatment Business (2018-2023)
11.7.5 RaNA Therapeutics Recent Developments
11.8 Silence Therapeutics
11.8.1 Silence Therapeutics Company Details
11.8.2 Silence Therapeutics Business Overview
11.8.3 Silence Therapeutics mRNA Treatment Introduction
11.8.4 Silence Therapeutics Revenue in mRNA Treatment Business (2018-2023)
11.8.5 Silence Therapeutics Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global mRNA Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Vaccine
Table 3. Key Players of Drugs
Table 4. Global mRNA Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global mRNA Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global mRNA Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global mRNA Treatment Market Share by Region (2018-2023)
Table 8. Global mRNA Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global mRNA Treatment Market Share by Region (2024-2029)
Table 10. mRNA Treatment Market Trends
Table 11. mRNA Treatment Market Drivers
Table 12. mRNA Treatment Market Challenges
Table 13. mRNA Treatment Market Restraints
Table 14. Global mRNA Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global mRNA Treatment Revenue Share by Players (2018-2023)
Table 16. Global Top mRNA Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Treatment as of 2022)
Table 17. Global mRNA Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by mRNA Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of mRNA Treatment, Headquarters and Area Served
Table 20. Global Key Players of mRNA Treatment, Product and Application
Table 21. Global Key Players of mRNA Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global mRNA Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global mRNA Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global mRNA Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global mRNA Treatment Revenue Share by Application (2018-2023)
Table 29. Global mRNA Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global mRNA Treatment Revenue Share by Application (2024-2029)
Table 31. North America mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America mRNA Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America mRNA Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe mRNA Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe mRNA Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. China mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 46. China mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 47. China mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 48. China mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia mRNA Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia mRNA Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia mRNA Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America mRNA Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America mRNA Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 63. CureVac Company Details
Table 64. CureVac Business Overview
Table 65. CureVac mRNA Treatment Product
Table 66. CureVac Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 67. CureVac Recent Developments
Table 68. Moderna Company Details
Table 69. Moderna Business Overview
Table 70. Moderna mRNA Treatment Product
Table 71. Moderna Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 72. Moderna Recent Developments
Table 73. BioNTech (Pfizer) Company Details
Table 74. BioNTech (Pfizer) Business Overview
Table 75. BioNTech (Pfizer) mRNA Treatment Product
Table 76. BioNTech (Pfizer) Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 77. BioNTech (Pfizer) Recent Developments
Table 78. Sanofi (Translate Bio) Company Details
Table 79. Sanofi (Translate Bio) Business Overview
Table 80. Sanofi (Translate Bio) mRNA Treatment Product
Table 81. Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 82. Sanofi (Translate Bio) Recent Developments
Table 83. Ethris (AstraZeneca) Company Details
Table 84. Ethris (AstraZeneca) Business Overview
Table 85. Ethris (AstraZeneca) mRNA Treatment Product
Table 86. Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 87. Ethris (AstraZeneca) Recent Developments
Table 88. Kernal Biologics Company Details
Table 89. Kernal Biologics Business Overview
Table 90. Kernal Biologics mRNA Treatment Product
Table 91. Kernal Biologics Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 92. Kernal Biologics Recent Developments
Table 93. RaNA Therapeutics Company Details
Table 94. RaNA Therapeutics Business Overview
Table 95. RaNA Therapeutics mRNA Treatment Product
Table 96. RaNA Therapeutics Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 97. RaNA Therapeutics Recent Developments
Table 98. Silence Therapeutics Company Details
Table 99. Silence Therapeutics Business Overview
Table 100. Silence Therapeutics mRNA Treatment Product
Table 101. Silence Therapeutics Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 102. Silence Therapeutics Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 1. Global mRNA Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Vaccine
Table 3. Key Players of Drugs
Table 4. Global mRNA Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global mRNA Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global mRNA Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global mRNA Treatment Market Share by Region (2018-2023)
Table 8. Global mRNA Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global mRNA Treatment Market Share by Region (2024-2029)
Table 10. mRNA Treatment Market Trends
Table 11. mRNA Treatment Market Drivers
Table 12. mRNA Treatment Market Challenges
Table 13. mRNA Treatment Market Restraints
Table 14. Global mRNA Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global mRNA Treatment Revenue Share by Players (2018-2023)
Table 16. Global Top mRNA Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Treatment as of 2022)
Table 17. Global mRNA Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by mRNA Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of mRNA Treatment, Headquarters and Area Served
Table 20. Global Key Players of mRNA Treatment, Product and Application
Table 21. Global Key Players of mRNA Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global mRNA Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global mRNA Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global mRNA Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global mRNA Treatment Revenue Share by Application (2018-2023)
Table 29. Global mRNA Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global mRNA Treatment Revenue Share by Application (2024-2029)
Table 31. North America mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America mRNA Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America mRNA Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe mRNA Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe mRNA Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. China mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 46. China mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 47. China mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 48. China mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia mRNA Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia mRNA Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia mRNA Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America mRNA Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America mRNA Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America mRNA Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America mRNA Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 63. CureVac Company Details
Table 64. CureVac Business Overview
Table 65. CureVac mRNA Treatment Product
Table 66. CureVac Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 67. CureVac Recent Developments
Table 68. Moderna Company Details
Table 69. Moderna Business Overview
Table 70. Moderna mRNA Treatment Product
Table 71. Moderna Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 72. Moderna Recent Developments
Table 73. BioNTech (Pfizer) Company Details
Table 74. BioNTech (Pfizer) Business Overview
Table 75. BioNTech (Pfizer) mRNA Treatment Product
Table 76. BioNTech (Pfizer) Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 77. BioNTech (Pfizer) Recent Developments
Table 78. Sanofi (Translate Bio) Company Details
Table 79. Sanofi (Translate Bio) Business Overview
Table 80. Sanofi (Translate Bio) mRNA Treatment Product
Table 81. Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 82. Sanofi (Translate Bio) Recent Developments
Table 83. Ethris (AstraZeneca) Company Details
Table 84. Ethris (AstraZeneca) Business Overview
Table 85. Ethris (AstraZeneca) mRNA Treatment Product
Table 86. Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 87. Ethris (AstraZeneca) Recent Developments
Table 88. Kernal Biologics Company Details
Table 89. Kernal Biologics Business Overview
Table 90. Kernal Biologics mRNA Treatment Product
Table 91. Kernal Biologics Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 92. Kernal Biologics Recent Developments
Table 93. RaNA Therapeutics Company Details
Table 94. RaNA Therapeutics Business Overview
Table 95. RaNA Therapeutics mRNA Treatment Product
Table 96. RaNA Therapeutics Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 97. RaNA Therapeutics Recent Developments
Table 98. Silence Therapeutics Company Details
Table 99. Silence Therapeutics Business Overview
Table 100. Silence Therapeutics mRNA Treatment Product
Table 101. Silence Therapeutics Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 102. Silence Therapeutics Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global mRNA Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global mRNA Treatment Market Share by Type: 2022 VS 2029
Figure 3. Vaccine Features
Figure 4. Drugs Features
Figure 5. Global mRNA Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global mRNA Treatment Market Share by Application: 2022 VS 2029
Figure 7. Protein Diseases Case Studies
Figure 8. Gene Dysfunction Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. mRNA Treatment Report Years Considered
Figure 11. Global mRNA Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global mRNA Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global mRNA Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global mRNA Treatment Market Share by Players in 2022
Figure 15. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by mRNA Treatment Revenue in 2022
Figure 17. North America mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America mRNA Treatment Market Share by Type (2018-2029)
Figure 19. North America mRNA Treatment Market Share by Application (2018-2029)
Figure 20. North America mRNA Treatment Market Share by Country (2018-2029)
Figure 21. United States mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe mRNA Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe mRNA Treatment Market Share by Type (2018-2029)
Figure 25. Europe mRNA Treatment Market Share by Application (2018-2029)
Figure 26. Europe mRNA Treatment Market Share by Country (2018-2029)
Figure 27. Germany mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China mRNA Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China mRNA Treatment Market Share by Type (2018-2029)
Figure 35. China mRNA Treatment Market Share by Application (2018-2029)
Figure 36. Asia mRNA Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia mRNA Treatment Market Share by Type (2018-2029)
Figure 38. Asia mRNA Treatment Market Share by Application (2018-2029)
Figure 39. Asia mRNA Treatment Market Share by Region (2018-2029)
Figure 40. Japan mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America mRNA Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America mRNA Treatment Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America mRNA Treatment Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America mRNA Treatment Market Share by Country (2018-2029)
Figure 50. Brazil mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. CureVac Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 57. Moderna Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 58. BioNTech (Pfizer) Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 59. Sanofi (Translate Bio) Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 60. Ethris (AstraZeneca) Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 61. Kernal Biologics Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 62. RaNA Therapeutics Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 63. Silence Therapeutics Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Figure 1. Global mRNA Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global mRNA Treatment Market Share by Type: 2022 VS 2029
Figure 3. Vaccine Features
Figure 4. Drugs Features
Figure 5. Global mRNA Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global mRNA Treatment Market Share by Application: 2022 VS 2029
Figure 7. Protein Diseases Case Studies
Figure 8. Gene Dysfunction Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. mRNA Treatment Report Years Considered
Figure 11. Global mRNA Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global mRNA Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global mRNA Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global mRNA Treatment Market Share by Players in 2022
Figure 15. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by mRNA Treatment Revenue in 2022
Figure 17. North America mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America mRNA Treatment Market Share by Type (2018-2029)
Figure 19. North America mRNA Treatment Market Share by Application (2018-2029)
Figure 20. North America mRNA Treatment Market Share by Country (2018-2029)
Figure 21. United States mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe mRNA Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe mRNA Treatment Market Share by Type (2018-2029)
Figure 25. Europe mRNA Treatment Market Share by Application (2018-2029)
Figure 26. Europe mRNA Treatment Market Share by Country (2018-2029)
Figure 27. Germany mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China mRNA Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China mRNA Treatment Market Share by Type (2018-2029)
Figure 35. China mRNA Treatment Market Share by Application (2018-2029)
Figure 36. Asia mRNA Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia mRNA Treatment Market Share by Type (2018-2029)
Figure 38. Asia mRNA Treatment Market Share by Application (2018-2029)
Figure 39. Asia mRNA Treatment Market Share by Region (2018-2029)
Figure 40. Japan mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America mRNA Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America mRNA Treatment Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America mRNA Treatment Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America mRNA Treatment Market Share by Country (2018-2029)
Figure 50. Brazil mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries mRNA Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. CureVac Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 57. Moderna Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 58. BioNTech (Pfizer) Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 59. Sanofi (Translate Bio) Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 60. Ethris (AstraZeneca) Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 61. Kernal Biologics Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 62. RaNA Therapeutics Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 63. Silence Therapeutics Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
